CA3092752A1 - Transdermal therapeutic system comprising a silicone acrylic hybrid polymer - Google Patents

Transdermal therapeutic system comprising a silicone acrylic hybrid polymer Download PDF

Info

Publication number
CA3092752A1
CA3092752A1 CA3092752A CA3092752A CA3092752A1 CA 3092752 A1 CA3092752 A1 CA 3092752A1 CA 3092752 A CA3092752 A CA 3092752A CA 3092752 A CA3092752 A CA 3092752A CA 3092752 A1 CA3092752 A1 CA 3092752A1
Authority
CA
Canada
Prior art keywords
active agent
therapeutic system
transdermal therapeutic
silicone
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3092752A
Other languages
English (en)
French (fr)
Inventor
Marco Emgenbroich
Gabriel WAUER
Michael Linn
Rolf Bohm
Christoph Schmitz
Regine Kaufmann
Hans-Werner Wolf
Nico Reum
Anna Schluter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CA3092752A1 publication Critical patent/CA3092752A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3092752A 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer Pending CA3092752A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161436.3 2018-03-13
EP18161436 2018-03-13
PCT/EP2019/056025 WO2019175106A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (1)

Publication Number Publication Date
CA3092752A1 true CA3092752A1 (en) 2019-09-19

Family

ID=61628188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3092752A Pending CA3092752A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Country Status (7)

Country Link
US (1) US20210008000A1 (cg-RX-API-DMAC7.html)
EP (1) EP3764997A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021515791A (cg-RX-API-DMAC7.html)
CN (1) CN111971033A (cg-RX-API-DMAC7.html)
BR (1) BR112020018290A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092752A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019175106A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3069698T3 (en) * 2023-09-28 2026-06-09 Lts Lohmann Therapie Systeme Ag Transdermal therapeutic system comprising cytisine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) * 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
KR102048682B1 (ko) 2015-02-09 2019-11-27 다우 실리콘즈 코포레이션 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
WO2018015424A1 (en) * 2016-07-22 2018-01-25 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Also Published As

Publication number Publication date
EP3764997A1 (en) 2021-01-20
US20210008000A1 (en) 2021-01-14
WO2019175106A1 (en) 2019-09-19
BR112020018290A2 (pt) 2020-12-29
CN111971033A (zh) 2020-11-20
JP2021515791A (ja) 2021-06-24

Similar Documents

Publication Publication Date Title
CA3079696A1 (en) Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer
AU2018348802A1 (en) Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive
EP3678647A1 (en) Transdermal therapeutic system for the transdermal administration of rivastigmine
CA3146233A1 (en) Transdermal therapeutic system comprising an active agent-containing layer comprising a silicone-containing polymer and a skin contact layer comprising a silicone gel adhesive
US20210052569A1 (en) Transdermal therapeutic system containing nicotine and silicone acrylic hybrid polymer
US20210145760A1 (en) Transdermal therapeutic system containing scopolamine and silicone acrylic hybrid polymer
US12121616B2 (en) Transdermal therapeutic system for the transdermal administration of solifenacin
US20210000756A1 (en) Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
US20210038532A1 (en) Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
US20210008000A1 (en) Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
US20210000755A1 (en) Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymer
WO2021078761A1 (en) Transdermal therapeutic system for the transdermal administration of fingolimod
HK40043162A (en) Transdermal therapeutic system for the transdermal administration of solifenacin